Arcutis Biotherapeutics
Develops ZORYVE topical treatments for plaque psoriasis, atopic dermatitis, and seborrheic dermatitis.
$23.74
After-hours close−0.03 (−0.13%)
At close$23.77(−4.42%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 108.47%Insiders 2.20%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 125.08M · Float 110.19M · 88.1% free float
Institutions13F, as of Jun 30, 2026
281 holders · 135.68M shares · 45 new positions · 138 increased · 101 reduced · 41 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 12.44M | 9.94% | +110.0K | Aug 14, 2026 |
| BlackRock, Inc. | 10.55M | 8.43% | +1.35M | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 9.87M | 7.89% | 0 | Aug 14, 2026 |
| Rubric Capital Management LP | 8.27M | 6.61% | 0 | Aug 14, 2026 |
| Polar Capital Holdings PLC | 6.61M | 5.28% | +940.0K | Aug 14, 2026 |
| State Street Corp | 5.82M | 4.66% | −473.4K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 4.99M | 3.99% | +117.2K | Aug 13, 2026 |
| Morgan Stanley | 4.45M | 3.56% | +232.1K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Patrick J. Heronincl. Fhmls X, L.L.C., Frazier Life Sciences Public Fund, L.P. +17 more | 7.50% | 8.94M | 13D | Aug 20, 2025 ↗ |
| Rubric Capital Management LP | 6.75% | 8.27M | 13G | Feb 13, 2026 ↗ |
| Polar Capital Holdings Plc | 5.28% | 6.61M | 13G | Aug 14, 2026 ↗ |
| State Street Corporation | 5.10% | 6.30M | 13G | May 12, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Bhaskar Chaudhuri | director | 867.8K | 0.69% | Jun 16, 2025 |
| Todd Watanabe | director, officer: See Remarks | 742.6K | 0.59% | Aug 5, 2026 |
| Christopher Peetz | director | 191.8K | 0.15% | Jul 17, 2026 |
| David Joseph Topper | officer: Chief Financial Officer | 182.8K | 0.15% | Apr 3, 2025 |
| Larry Todd Edwards | officer: See Remarks | 175.2K | 0.14% | Mar 3, 2026 |
| Masaru Matsuda | officer: See Remarks | 126.2K | 0.10% | Aug 5, 2026 |
| Patrick Burnett | officer: See Remarks | 117.6K | 0.09% | Aug 21, 2026 |
| Latha Vairavan | officer: SVP Chief Financial Officer | 86.0K | 0.07% | May 13, 2026 |
| Patrick J. Heron | director | 59.7K | 0.05% | Jun 9, 2026 |
| Terrie Curran | director | 50.6K | 0.04% | Aug 28, 2026 |
3 ten-percent owners hold 12.00M shares by Form 4, outside the officers-and-directors figure above · 9 people have not refiled in the last 18 months (1.92M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 27, 2026 | Terrie Currandirector | Sale | 27,052 | $25.03 | 23,526 |
| Aug 20, 2026 | Terrie Currandirector | Sale | 1,072 | $26.04 | 23,526 |
| Aug 19, 2026 | Patrick Burnettofficer: See Remarks | Sale | 1,697 | $27.00 | 117,592 |
| Aug 17, 2026 | Howard G. Welgusdirector | Sale | 4,730 | $26.18 | 36,475 |
| Aug 12, 2026 | Patrick Burnettofficer: See Remarks | Sale | 6,700 | $26.08 | 119,289 |
| Aug 11, 2026 | Patrick Burnettofficer: See Remarks | Sale | 8,300 | $26.52 | 119,289 |
| Aug 3, 2026 | Todd Watanabedirector, officer: See Remarks | Sale | 4,375 | $26.12 | 717,203 |
| Aug 3, 2026 | Masaru Matsudaofficer: See Remarks | Sale | 1,230 | $26.12 | 126,171 |
| Aug 3, 2026 | Patrick Burnettofficer: See Remarks | Sale | 955 | $26.12 | 119,289 |
| Jul 15, 2026 | Howard G. Welgusdirector | Sale | 4,730 | $26.91 | 37,109 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | May 29, 2026 | Jun 9, 2026 ↗ | |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | Mar 3, 2026 | Apr 8, 2026 ↗ |